Cipla Ltd.

Cipla has informed that it has enclosed press release dated 14th July 2020 titled ‘Cipla receives final approval for generic version of Shire’s Firazyr® (Icatibant Injectable Pre-Filled Syringe 30mg/3mL)’.

The above information is a part of company’s filings submitted to BSE.